Local Institution
The Bronx, New York 10466
0 studies enrolling now · 14 studies all time
What they study most
AIDS, Bladder Cancer, Bladder Neoplasms, Breast Cancer, Cancer, Congestive Heart Failure, HIV Infections, Hypertension, Kidney Neoplasms, Melanoma, Metastatic Colorectal Cancer, Neoplasm, Bladder
Studies at this site
- Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer — Completed
- Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer — Completed
- An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer — Completed
- Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve) — Completed
- Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases — Completed
- Abatacept With Methotrexate- Phase IIB — Completed
- A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate — Completed
- Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily Regimen — Completed
- DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy — Completed
- Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension — Completed
- Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension — Completed
- Atazanavir for HIV Infected Individuals: An Early Access Program — NO_LONGER_AVAILABLE
- Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium — Completed
- A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy — Stopped early